IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
BETHESDA, Md.–(BUSINESS WIRE)–India Globalization Capital, Inc. (NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer’s drug development…
Details